There could be a major initial public offering (IPO) coming this week—and it’s not from a tech or AI company. The sandwich ...

Latigo Biotherapeutics is advancing a pipeline of non-opioid pain treatments, with lead candidate LTG-001 showing promising ...

Wealth Enhancement reports on IPOs, explaining their pros and cons, how to invest in them, risks involved, and alternative ...

Shares of SpaceX have cratered by 50% from their all-time high.

IPO, if you’re on the friends and family list and can get the initial IPO price, then … maybe. Otherwise, avoid the hype.

There are a lot of things happening for SpaceX next week.

As Elon Musk's SpaceX makes its historic public debut on the stock market, cooler heads are decidedly not prevailing.

SpaceX has struggled since its debut, and history shows that offerings since 2019 have underperformed in the years since.

SpaceX went public on June 12 priced at $135 a share.

The fundraising attracted several institutional investors, including the Africa Finance Corporation and African Export-Import ...

Will the ₹9,275 crore Manipal Health IPO deliver strong long-term returns? In this exclusive episode of Centre Point, Surabhi Upadhyay speaks with Dilip Jose, MD & CEO, Manipal Health Enterprises, on ...

Anand Rathi recommends a Subscribe Long Term rating for Manipal Health Enterprises Ltd's IPO, highlighting its extensive ...